CD8A and neoplasm: 1. Tranilast enhances CD8+ T cell infiltration and reduces M2 macrophages.2. Futibatinib demonstrates anti-tumor efficacy in various malignancies, including GC.3. Metformin modulates CAFs to inhibit tumor progression.